A total of 90 institutions have reported a stake in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) as of September 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 30 Sep, 2025 | 10,744,107 | 231,973 | 2.21% | $40,721.00 |
| Vestal Point Capital, LP | 30 Sep, 2025 | 5,550,000 | -50,000 | -0.89% | $21,034,500.00 |
| NEA Management Company, LLC | 30 Sep, 2025 | 4,448,757 | 0 | 0.00% | $16,860,789.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 2,188,857 | 85,825 | 4.08% | $8,295,768.00 |
| TANG CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 2,070,209 | 0 | 0.00% | $7,846,092.00 |
| MARSHALL WACE, LLP | 30 Sep, 2025 | 1,299,208 | 561,333 | 76.07% | $4,923,996.00 |
| Siren, L.L.C. | 30 Sep, 2025 | 1,046,517 | 0 | 0.00% | $3,966,299.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 1,028,092 | -62,771 | -5.75% | $3,896,470.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 30 Sep, 2025 | 896,853 | 758,709 | 549.22% | $3,399,073.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 850,331 | -94,522 | -10.00% | $3,222,754.00 |
| UBS Group AG | 30 Sep, 2025 | 628,416 | 314,716 | 100.32% | $2,381,696.00 |
| AWM Investment Company, Inc. | 30 Sep, 2025 | 600,000 | 100,000 | 20.00% | $2,274,000.00 |
| RENAISSANCE TECHNOLOGIES LLC | 30 Sep, 2025 | 599,400 | 432,300 | 258.71% | $2,271,726.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 500,523 | 5,180 | 1.05% | $1,897,600.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 488,064 | 336,643 | 222.32% | $1,849,763.00 |
| ACADIAN ASSET MANAGEMENT LLC | 30 Sep, 2025 | 481,123 | 466,152 | 3,113.70% | $1,820.00 |
| DIMENSIONAL FUND ADVISORS LP | 30 Sep, 2025 | 455,870 | 0 | 0.00% | $1,727,463.00 |
| FMR LLC | 30 Sep, 2025 | 453,558 | 39,672 | 9.59% | $1,718,985.00 |
| GOLDMAN SACHS GROUP INC | 30 Sep, 2025 | 449,018 | 98,374 | 28.06% | $1,701,779.00 |
| DAFNA Capital Management LLC | 30 Sep, 2025 | 307,070 | -163,930 | -34.80% | $1,163,795.00 |